Sword Bio has optimized a number of proprietary assays to support the analysis of antibody-drug conjugates (ADCs) with significantly improved sensitivity, precision, and performance. If you would like to obtain an assay as a customized solution for your ADC project, you can request more information here.
Sword scientists will use our cell-based assay development expertise to develop a customized method to corroborate the binding specificity of your antibody-drug conjugate (ADC).
Our understanding of the molecular basis of cellular growth, proliferation, and differentiation is continually evolving as the genes, proteins, and biochemical pathways critical to these important cellular processes are investigated and understood.
Based on your specifications, our scientists will develop a bioanalytical method that will demonstrate the binding of your ADC to the cellular target of interest. The bioanalytical method will be performance qualified as fit for the assay’s purpose, whether the ADC is in early stage research and development or later stage preclinical.
Contact us today to discuss how our proprietary Sword Swift™ Method Development Process, Sword Swift™ Detection Reagents, and our scientific method development expertise can be utilized to speed your drug or diagnostic assay development processes.